Dr. Reddy's Laboratories Stock Rises 4.27% Over Five Days, Market Cap at Rs 1.03 Lakh Crore

Dr Reddy's Laboratories, a prominent player in the Pharmaceuticals & Biotechnology sector, has shown notable activity today, maintaining performance in line with the sector. The stock has experienced a consecutive gain over the past five days, yielding a return of 4.27% during this period. Today, it opened at Rs 1249.6 and has traded consistently at this price.
In terms of moving averages, Dr Reddy's stock is currently above its 5-day, 20-day, and 200-day moving averages, while it remains below the 50-day and 100-day moving averages. The company's market capitalization stands at Rs 1,03,825.95 crore, categorizing it as a large-cap stock. The price-to-earnings (P/E) ratio is reported at 18.00, significantly lower than the industry average of 34.47.

Over the past year, Dr Reddy's Laboratories has delivered a performance of 1.19%, contrasting with the Sensex's 9.13%. In the short term, the stock has faced challenges, with a year-to-date decline of 10.39% compared to the Sensex's gain of 8.35%. Overall, the stock's performance reflects a complex landscape within the pharmaceuticals sector, where 27 stocks have reported results, with 9 showing positive outcomes.